Akero Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Akero Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akero Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akero Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.1M | 47k | 23.35 |
| 2023-09-30 | $2.4M | 47k | 50.58 |
| 2023-06-30 | $1.5M | 38k | 38.25 |
| 2023-03-31 | $1.5M | 38k | 38.25 |
| 2022-12-31 | $2.0M | 36k | 54.80 |
| 2022-09-30 | $838k | 25k | 34.05 |
| 2022-06-30 | $320k | 34k | 9.45 |
| 2022-03-31 | $265k | 19k | 14.19 |
| 2021-03-31 | $212k | 7.3k | 29.01 |
| 2020-12-31 | $217k | 8.4k | 25.80 |
| 2020-09-30 | $259k | 8.4k | 30.79 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas